Literature DB >> 6356795

Stereotaxic needle biopsy of non-palpable breast lesions. Cytologic and histopathologic findings.

G Svane, C Silfverswärd.   

Abstract

Stereotaxic needle biopsy was performed on 121 radiographically demonstrated non-palpable breast lesions, which were excised within 3 months after the needling. Of the 62 histopathologically proven malignant tumors, malignant or probably malignant epithelial cells were obtained at needle biopsy, in about 80 per cent of cases, in which the cellular material was quantitatively adequate. There was no false positive cytologic result. The combined radiologic and cytologic assessment gave a correct diagnosis in 61 of the 62 histopathologically malignant tumors. There was metastatic tumor involvement of the lymph nodes in only 3 of the malignant tumors.

Entities:  

Mesh:

Year:  1983        PMID: 6356795     DOI: 10.1177/028418518302400402

Source DB:  PubMed          Journal:  Acta Radiol Diagn (Stockh)        ISSN: 0567-8056


  5 in total

Review 1.  Percutaneous biopsies of the breast: state of the art.

Authors:  B D Fornage
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Jan-Feb       Impact factor: 2.740

2.  Stereotaxic needle localization and cytological diagnosis of occult breast lesions.

Authors:  H J Gent; E Sprenger; K Dowlatshahi
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

3.  Role of fine needle aspiration cytology in breast cancer screening.

Authors:  J Lamb; T J Anderson; M J Dixon; P A Levack
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

4.  Stereotactic fine-needle aspiration biopsy for the evaluation of nonpalpable breast lesions: report of an experience based on 2,988 cases.

Authors:  J S Mitnick; M F Vazquez; P I Pressman; M N Harris; D F Roses
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

5.  Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy.

Authors:  R A Mikhail; R C Nathan; M Weiss; R M Tummala; U R Mullangi; L Lawrence; A Mukkamala
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.